Lisata Therapeutics, Inc. (LSTA)
(Delayed Data from NSDQ)
$2.94 USD
+0.01 (0.36%)
Updated Aug 6, 2024 03:39 PM ET
After-Market: $3.00 +0.06 (2.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC8/12/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -0.65 |
Last EPS Surprise | 10.96% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.08 |
Next Year | -2.69 |
EPS (TTM) | -2.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.77 | -3.08 | -2.69 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.74 | -0.73 | -2.94 | -3.04 |
High Estimate | -0.74 | -0.73 | -2.94 | -2.33 |
Low Estimate | -0.76 | -0.80 | -3.22 | -3.04 |
Year ago EPS | -0.50 | -0.65 | -2.58 | -3.08 |
Year over Year Growth Est. | -50.00% | -18.46% | -19.38% | 12.82% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.77 | -3.08 | -2.69 |
7 Days Ago | -0.75 | -0.77 | -3.08 | -2.69 |
30 Days Ago | -0.75 | -0.77 | -3.08 | -2.69 |
60 Days Ago | -0.75 | -0.77 | -3.08 | -2.69 |
90 Days Ago | -0.75 | -0.77 | -3.08 | -2.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.77 | -3.08 | -2.69 |
Zacks Consensus Estimate | -0.75 | -0.77 | -3.08 | -2.69 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.65 | -0.66 | -0.65 | -0.50 | NA |
Estimate | -0.73 | -0.86 | -0.93 | -0.70 | NA |
Difference | 0.08 | 0.20 | 0.28 | 0.20 | 0.19 |
Surprise | 10.96% | 23.26% | 30.11% | 28.57% | 23.23% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more